利妥昔单抗相关低丙种球蛋白血症在肾病综合征中的临床意义：治疗还是不治疗？ - Suppr

Suppr

超能文献

Clinical significance of rituximab-associated hypogammaglobulinemia in nephrotic syndrome: to treat or not to treat?

作者信息

Chan Eugene Yu-Hin

机构信息

Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR.

Department of Paediatrics, Chinese University of Hong Kong, Shatin, Hong Kong SAR.

出版信息

Pediatr Nephrol. 2024 Dec;39(12):3621. doi: 10.1007/s00467-024-06379-5. Epub 2024 Apr 19.

DOI:10.1007/s00467-024-06379-5

PMID:38639775

Abstract

摘要

相似文献

Clinical significance of rituximab-associated hypogammaglobulinemia in nephrotic syndrome: to treat or not to treat?利妥昔单抗相关低丙种球蛋白血症在肾病综合征中的临床意义：治疗还是不治疗？

Pediatr Nephrol. 2024 Dec;39(12):3621. doi: 10.1007/s00467-024-06379-5. Epub 2024 Apr 19.

Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome.复杂型肾病综合征患者中利妥昔单抗相关低丙种球蛋白血症的发病率及危险因素

Pediatr Nephrol. 2022 May;37(5):1057-1066. doi: 10.1007/s00467-021-05304-4. Epub 2021 Oct 4.

Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.利妥昔单抗治疗的激素依赖性肾病综合征患者的血清免疫球蛋白水平。

Pediatr Nephrol. 2020 Mar;35(3):455-462. doi: 10.1007/s00467-019-04398-1. Epub 2019 Nov 8.

The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome.利妥昔单抗治疗的儿童期起病的特发性肾病综合征患者低丙种球蛋白血症严重程度与感染风险之间的关联。

Pediatr Nephrol. 2023 Feb;38(2):451-460. doi: 10.1007/s00467-022-05652-9. Epub 2022 Jun 24.

Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effects.序贯利妥昔单抗治疗可维持肾病综合征的缓解，但不良反应风险较高。

Nephrol Dial Transplant. 2023 Mar 31;38(4):939-949. doi: 10.1093/ndt/gfac228.

Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.重复利妥昔单抗维持缓解治疗特发性儿童肾病综合征的长期疗效和安全性：一项国际研究。

J Am Soc Nephrol. 2022 Jun;33(6):1193-1207. doi: 10.1681/ASN.2021111472. Epub 2022 Mar 30.

Rituximab in children with steroid sensitive nephrotic syndrome: in quest of the optimal regimen.利妥昔单抗治疗儿童激素敏感性肾病综合征：探寻最佳方案。

Pediatr Nephrol. 2021 Jun;36(6):1397-1405. doi: 10.1007/s00467-020-04609-0. Epub 2020 Jun 24.

Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey.特利珠单抗相关低丙种球蛋白血症在特发性肾病综合征儿童中的表现：一项 ESPN 调查的结果。

Pediatr Nephrol. 2023 Sep;38(9):3035-3042. doi: 10.1007/s00467-023-05913-1. Epub 2023 Apr 4.

Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study.利妥昔单抗治疗儿童难治性肾病综合征：一项多中心回顾性研究。

Turk J Med Sci. 2021 Aug 30;51(4):1781-1790. doi: 10.3906/sag-2012-297.

Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome.利妥昔单抗在儿童特发性肾病综合征中的应用。

Clin J Am Soc Nephrol. 2023 Apr 1;18(4):533-548. doi: 10.2215/CJN.08570722. Epub 2023 Feb 22.

引用本文的文献

Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines.儿童特发性肾病综合征：塑造未来指南的最新进展

Pediatr Nephrol. 2024 Dec 26. doi: 10.1007/s00467-024-06634-9.

本文引用的文献

Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis.利妥昔单抗作为添加治疗用于严重儿童发病狼疮性肾炎的长期结果。

Pediatr Nephrol. 2023 Dec;38(12):4001-4011. doi: 10.1007/s00467-023-06025-6. Epub 2023 Jun 26.

Pediatr Nephrol. 2023 Sep;38(9):3035-3042. doi: 10.1007/s00467-023-05913-1. Epub 2023 Apr 4.

Hypogammaglobulinaemia following rituximab therapy in childhood nephrotic syndrome.儿童肾病综合征患者接受利妥昔单抗治疗后出现低丙种球蛋白血症。

Pediatr Nephrol. 2022 May;37(5):927-931. doi: 10.1007/s00467-021-05345-9. Epub 2022 Jan 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验